140 related articles for article (PubMed ID: 2098296)
1. Ciprofloxacin for infection prophylaxis in granulocytopenic patients with acute leukemia.
Cortellaro M; Cofrancesco E; Pasargiklian I; Bianchi R; Pozzoli E; Annaloro C; Ranzi ML; Mascheroni E; Polli N
Haematologica; 1990; 75(6):541-5. PubMed ID: 2098296
[TBL] [Abstract][Full Text] [Related]
2. Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.
Winston DJ; Ho WG; Nakao SL; Gale RP; Champlin RE
Am J Med; 1986 May; 80(5):884-90. PubMed ID: 3010716
[TBL] [Abstract][Full Text] [Related]
3. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.
Dekker AW; Rozenberg-Arska M; Verhoef J
Ann Intern Med; 1987 Jan; 106(1):7-11. PubMed ID: 3466563
[TBL] [Abstract][Full Text] [Related]
4. Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin.
Dennig D; Fülle HH; Hellriegel KP
Onkologie; 1987 Feb; 10(1):57-8. PubMed ID: 3295628
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of ciprofloxacin with polymyxin B for infection prophylaxis in neutropenic patients with acute non-lymphocytic leukemia].
Moriuchi Y; Kamihira S; Yamamura M; Mori H; Miyazaki Y; Tokunaga S; Nonaka H; Amagasaki T; Yamada Y; Yoshida Y
Rinsho Ketsueki; 1990 Oct; 31(10):1664-9. PubMed ID: 2123946
[TBL] [Abstract][Full Text] [Related]
6. Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin vs ciprofloxacin plus amoxicillin.
Fanci R; Leoni F; Bosi A; Guidi S; Ciolli S; Longo G; Donnini E; Rossi Ferrini P
J Chemother; 1993 Apr; 5(2):119-23. PubMed ID: 8515294
[TBL] [Abstract][Full Text] [Related]
7. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.
Wade JC; de Jongh CA; Newman KA; Crowley J; Wiernik PH; Schimpff SC
J Infect Dis; 1983 Apr; 147(4):624-34. PubMed ID: 6842003
[TBL] [Abstract][Full Text] [Related]
8. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of bacterial infections using ciprofloxacin in granulocytopenic patients with cancer].
Snoeck R; Gerain J; Leleux A; Libert J; Meunier F
Rev Med Brux; 1989 Dec; 10(10):408-13. PubMed ID: 2602729
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patients.
Jones PG; Kauffman CA; McAuliffe LS; Liepman MK; Bergman AG
Arch Intern Med; 1984 Mar; 144(3):549-51. PubMed ID: 6322710
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
[TBL] [Abstract][Full Text] [Related]
12. [Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia].
López A; Soler JA; Juliá A; Novo A; Bueno J
Med Clin (Barc); 1994 Jan; 102(3):81-5. PubMed ID: 8133717
[TBL] [Abstract][Full Text] [Related]
13. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.
Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
Am J Med; 1990 Jan; 88(1):36-42. PubMed ID: 2153006
[TBL] [Abstract][Full Text] [Related]
14. Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients.
Smith GM; Leyland MJ; Farrell ID; Geddes AM
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():165-74. PubMed ID: 3468101
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
Zinner SH
Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995
[TBL] [Abstract][Full Text] [Related]
16. Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance.
Prentice HG; Hann IM; Nazareth B; Paterson P; Bhamra A; Kibbler CC
Br J Haematol; 2001 Oct; 115(1):46-52. PubMed ID: 11722408
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
D'Antonio D; Piccolomini R; Iacone A; Fioritoni G; Parruti G; Betti S; Quaglietta AM; Accorsi P; Dell'Isola M; Favalli C
J Antimicrob Chemother; 1994 Apr; 33(4):837-44. PubMed ID: 8056702
[TBL] [Abstract][Full Text] [Related]
18. Norfloxacin versus cotrimoxazole for infection prophylaxis in granulocytopenic patients with acute leukemia. A prospective randomized study.
Orlandi E; Navarra A; Cruciani M; Caldera D; Morra E; Castagnola C; Concia E; Bernasconi C
Haematologica; 1990; 75(3):296-8. PubMed ID: 2227631
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients.
Vogler WR; Malcom LG; Winton EF
Cancer Invest; 1987; 5(4):267-73. PubMed ID: 3664330
[TBL] [Abstract][Full Text] [Related]
20. Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group.
Donnelly JP; Maschmeyer G; Daenen S
Eur J Cancer; 1992; 28A(4-5):873-8. PubMed ID: 1524913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
